Collaborative study for the establishment of two European Pharmacopoeia Biological Reference Preparations for serological potency testing of tetanus vaccines for veterinary use.
The European Directorate for the Quality of Medicines (EDQM) has organised an international collaborative study, divided into two phases, aimed at producing and establishing two suitable reference sera for serological potency testing of tetanus vaccines for veterinary use for batch consistency demonstration. In phase I pools of sera were produced by immunising guinea pigs and rabbits with tetanus toxoid using the immunisation schedule prescribed by the European Pharmacopoeia (Ph. Eur.) for potency testing of tenanus vaccines for veterinary use. Following aliquoting and freeze-drying, characterization of the materials by immunochemical and biological assays enabled us to conclude that the sera should be suitable reference materials in respect of in-vitro assay methods for Clostridium (C.) tetani. The candidate (c) Ph. Eur. Biological Reference Preparations (BRP) were calibrated by Toxin Binding Inhibition test (ToBI) in phase II of the study by a large group of laboratories, including both manufacturers and official medicines control laboratories (OMCL). The activity of the proposed reference sera was determined by comparison with the existing equine monovalent World Health Organization (WHO) International Standard (IS). This study enabled us to provide a definitive value for the antitoxin activity of the reference preparations in respect of their anti-tetanus antibody content.
Lensing
H H
HH
ID-Lelystad, Lelystad, The Netherlands.
Behr-Gross
M E
ME
Daas
A
A
Spieser
J M
JM
D000826:Animal Testing Alternatives; D000818:Animals; D005060:Europe; D006168:Guinea Pigs; D066298:In Vitro Techniques; D010602:Pharmacopoeias as Topic; D011786:Quality Control; D011817:Rabbits; D012015:Reference Standards; D013742:Tetanus / Q000276:immunology / Q000517:prevention & control / Q000662:veterinary*; D013745:Tetanus Toxoid / Q000276:immunology* / Q000378:metabolism; D019155:Veterinary Drugs / Q000276:immunology* / Q000378:metabolism
D013745:Tetanus Toxoid; D019155:Veterinary Drugs